ALT
Altimmune Inc
3.00$
-4.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -94.3% | -43.0% | -39.3% | -10.8% | -12.1% | +3.4% | -10.0% | -3.7% | -11.5% | +0.0% | – | |
| – | -8.9% | +47.8% | +18.1% | -28.6% | +9.0% | +19.7% | -11.2% | -0.3% | +39.0% | -31.6% | -17.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +540.1% | -39.9% | -366.5% | – | -97.0% | -746.6% | – | +2.4% | -155.0% | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | +2,000.0% | +52.4% | – | |
| – | -280.8% | +396.6% | -90.6% | – | +1,036.9% | -137.4% | – | -247.7% | -47.0% | -95.3% | +5,901.2% | – | |
| – | +1,750.0% | +1,521.6% | -59.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +4,850.5% | – | – | – | |
| – | +12,273.1% | -100.4% | -82.4% | – | +3,691.4% | +238.3% | +53.1% | -24.7% | +106.2% | -3.3% | +169.0% | – | |
| – | – | -216.3% | – | – | – | +123.4% | +1,000.4% | -190.9% | – | – | -164.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.